Global Kidney Cancer Market Research Report 2023

Report ID: 1991666 | Published Date: Oct 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Surgery
        1.2.3 Immunotherapy
        1.2.4 Chemotherapy
        1.2.5 Radiation Therapy
    1.3 Market by Application
        1.3.1 Global Kidney Cancer Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Renal Cell Carcinoma (RCC)
        1.3.3 Transitional Cell Carcinoma (TCC)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Kidney Cancer Market Perspective (2017-2028)
    2.2 Kidney Cancer Growth Trends by Region
        2.2.1 Kidney Cancer Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Kidney Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Kidney Cancer Forecasted Market Size by Region (2023-2028)
    2.3 Kidney Cancer Market Dynamics
        2.3.1 Kidney Cancer Industry Trends
        2.3.2 Kidney Cancer Market Drivers
        2.3.3 Kidney Cancer Market Challenges
        2.3.4 Kidney Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Kidney Cancer Players by Revenue
        3.1.1 Global Top Kidney Cancer Players by Revenue (2017-2022)
        3.1.2 Global Kidney Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Kidney Cancer Revenue
    3.4 Global Kidney Cancer Market Concentration Ratio
        3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2021
    3.5 Kidney Cancer Key Players Head office and Area Served
    3.6 Key Players Kidney Cancer Product Solution and Service
    3.7 Date of Enter into Kidney Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Breakdown Data by Type
    4.1 Global Kidney Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Kidney Cancer Forecasted Market Size by Type (2023-2028)
5 Kidney Cancer Breakdown Data by Application
    5.1 Global Kidney Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Kidney Cancer Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Kidney Cancer Market Size (2017-2028)
    6.2 North America Kidney Cancer Market Size by Country (2017-2022)
    6.3 North America Kidney Cancer Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Kidney Cancer Market Size (2017-2028)
    7.2 Europe Kidney Cancer Market Size by Country (2017-2022)
    7.3 Europe Kidney Cancer Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Kidney Cancer Market Size (2017-2028)
    8.2 Asia-Pacific Kidney Cancer Market Size by Country (2017-2022)
    8.3 Asia-Pacific Kidney Cancer Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Kidney Cancer Market Size (2017-2028)
    9.2 Latin America Kidney Cancer Market Size by Country (2017-2022)
    9.3 Latin America Kidney Cancer Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Kidney Cancer Market Size (2017-2028)
    10.2 Middle East & Africa Kidney Cancer Market Size by Country (2017-2022)
    10.3 Middle East & Africa Kidney Cancer Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Kidney Cancer Introduction
        11.1.4 Merck Revenue in Kidney Cancer Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Kidney Cancer Introduction
        11.2.4 Novartis Revenue in Kidney Cancer Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Kidney Cancer Introduction
        11.3.4 AstraZeneca Revenue in Kidney Cancer Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Detail
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Kidney Cancer Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Kidney Cancer Introduction
        11.5.4 Pfizer Revenue in Kidney Cancer Business (2017-2022)
        11.5.5 Pfizer Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Kidney Cancer Introduction
        11.6.4 Roche Revenue in Kidney Cancer Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Detail
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Kidney Cancer Introduction
        11.7.4 Amgen Revenue in Kidney Cancer Business (2017-2022)
        11.7.5 Amgen Recent Development
    11.8 Argos Therapeutics
        11.8.1 Argos Therapeutics Company Detail
        11.8.2 Argos Therapeutics Business Overview
        11.8.3 Argos Therapeutics Kidney Cancer Introduction
        11.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2017-2022)
        11.8.5 Argos Therapeutics Recent Development
    11.9 Aveo Pharmaceuticals
        11.9.1 Aveo Pharmaceuticals Company Detail
        11.9.2 Aveo Pharmaceuticals Business Overview
        11.9.3 Aveo Pharmaceuticals Kidney Cancer Introduction
        11.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2017-2022)
        11.9.5 Aveo Pharmaceuticals Recent Development
    11.10 Bayer
        11.10.1 Bayer Company Detail
        11.10.2 Bayer Business Overview
        11.10.3 Bayer Kidney Cancer Introduction
        11.10.4 Bayer Revenue in Kidney Cancer Business (2017-2022)
        11.10.5 Bayer Recent Development
    11.11 Exelixis
        11.11.1 Exelixis Company Detail
        11.11.2 Exelixis Business Overview
        11.11.3 Exelixis Kidney Cancer Introduction
        11.11.4 Exelixis Revenue in Kidney Cancer Business (2017-2022)
        11.11.5 Exelixis Recent Development
    11.12 Incyte
        11.12.1 Incyte Company Detail
        11.12.2 Incyte Business Overview
        11.12.3 Incyte Kidney Cancer Introduction
        11.12.4 Incyte Revenue in Kidney Cancer Business (2017-2022)
        11.12.5 Incyte Recent Development
    11.13 Allergan
        11.13.1 Allergan Company Detail
        11.13.2 Allergan Business Overview
        11.13.3 Allergan Kidney Cancer Introduction
        11.13.4 Allergan Revenue in Kidney Cancer Business (2017-2022)
        11.13.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Surgery
    Table 3. Key Players of Immunotherapy
    Table 4. Key Players of Chemotherapy
    Table 5. Key Players of Radiation Therapy
    Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Kidney Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Kidney Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Kidney Cancer Market Share by Region (2017-2022)
    Table 10. Global Kidney Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Kidney Cancer Market Share by Region (2023-2028)
    Table 12. Kidney Cancer Market Trends
    Table 13. Kidney Cancer Market Drivers
    Table 14. Kidney Cancer Market Challenges
    Table 15. Kidney Cancer Market Restraints
    Table 16. Global Kidney Cancer Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Kidney Cancer Market Share by Players (2017-2022)
    Table 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2021)
    Table 19. Ranking of Global Top Kidney Cancer Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Kidney Cancer Product Solution and Service
    Table 23. Date of Enter into Kidney Cancer Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Kidney Cancer Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Kidney Cancer Revenue Market Share by Type (2017-2022)
    Table 27. Global Kidney Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Kidney Cancer Revenue Market Share by Type (2023-2028)
    Table 29. Global Kidney Cancer Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Kidney Cancer Revenue Market Share by Application (2017-2022)
    Table 31. Global Kidney Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Kidney Cancer Revenue Market Share by Application (2023-2028)
    Table 33. North America Kidney Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Kidney Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Kidney Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Kidney Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Kidney Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Kidney Cancer Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Kidney Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Kidney Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Kidney Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Kidney Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Kidney Cancer Product
    Table 46. Merck Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Kidney Cancer Product
    Table 51. Novartis Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. AstraZeneca Company Detail
    Table 54. AstraZeneca Business Overview
    Table 55. AstraZeneca Kidney Cancer Product
    Table 56. AstraZeneca Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 57. AstraZeneca Recent Development
    Table 58. Bristol-Myers Squibb Company Detail
    Table 59. Bristol-Myers Squibb Business Overview
    Table 60. Bristol-Myers Squibb Kidney Cancer Product
    Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 62. Bristol-Myers Squibb Recent Development
    Table 63. Pfizer Company Detail
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Kidney Cancer Product
    Table 66. Pfizer Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 67. Pfizer Recent Development
    Table 68. Roche Company Detail
    Table 69. Roche Business Overview
    Table 70. Roche Kidney Cancer Product
    Table 71. Roche Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 72. Roche Recent Development
    Table 73. Amgen Company Detail
    Table 74. Amgen Business Overview
    Table 75. Amgen Kidney Cancer Product
    Table 76. Amgen Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 77. Amgen Recent Development
    Table 78. Argos Therapeutics Company Detail
    Table 79. Argos Therapeutics Business Overview
    Table 80. Argos Therapeutics Kidney Cancer Product
    Table 81. Argos Therapeutics Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 82. Argos Therapeutics Recent Development
    Table 83. Aveo Pharmaceuticals Company Detail
    Table 84. Aveo Pharmaceuticals Business Overview
    Table 85. Aveo Pharmaceuticals Kidney Cancer Product
    Table 86. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 87. Aveo Pharmaceuticals Recent Development
    Table 88. Bayer Company Detail
    Table 89. Bayer Business Overview
    Table 90. Bayer Kidney Cancer Product
    Table 91. Bayer Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 92. Bayer Recent Development
    Table 93. Exelixis Company Detail
    Table 94. Exelixis Business Overview
    Table 95. Exelixis Kidney CancerProduct
    Table 96. Exelixis Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 97. Exelixis Recent Development
    Table 98. Incyte Company Detail
    Table 99. Incyte Business Overview
    Table 100. Incyte Kidney CancerProduct
    Table 101. Incyte Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 102. Incyte Recent Development
    Table 103. Allergan Company Detail
    Table 104. Allergan Business Overview
    Table 105. Allergan Kidney CancerProduct
    Table 106. Allergan Revenue in Kidney Cancer Business (2017-2022) & (US$ Million)
    Table 107. Allergan Recent Development
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Cancer Market Share by Type: 2021 VS 2028
    Figure 2. Surgery Features
    Figure 3. Immunotherapy Features
    Figure 4. Chemotherapy Features
    Figure 5. Radiation Therapy Features
    Figure 6. Global Kidney Cancer Market Share by Application in 2021 & 2028
    Figure 7. Renal Cell Carcinoma (RCC) Case Studies
    Figure 8. Transitional Cell Carcinoma (TCC) Case Studies
    Figure 9. Kidney Cancer Report Years Considered
    Figure 10. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Kidney Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Kidney Cancer Market Share by Region: 2021 VS 2028
    Figure 13. Global Kidney Cancer Market Share by Players in 2021
    Figure 14. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2021
    Figure 16. North America Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Kidney Cancer Market Share by Country (2017-2028)
    Figure 18. United States Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Kidney Cancer Market Share by Country (2017-2028)
    Figure 22. Germany Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Kidney Cancer Market Share by Region (2017-2028)
    Figure 30. China Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Kidney Cancer Market Share by Country (2017-2028)
    Figure 38. Mexico Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Kidney Cancer Market Share by Country (2017-2028)
    Figure 42. Turkey Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Kidney Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Merck Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 46. AstraZeneca Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 49. Roche Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 50. Amgen Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 51. Argos Therapeutics Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 52. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 53. Bayer Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 54. Exelixis Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 55. Incyte Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 56. Allergan Revenue Growth Rate in Kidney Cancer Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Allergan
Frequently Asked Questions
Kidney Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Kidney Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Kidney Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Leukemia Cancer

Leukemia Cancer market is segmented by players, region (country), by Type and by Application. Pla ... Read More